I would answer that in a different way. I think I have an ethical dilemma as a physician not to treat people with CCSVI. I think there is good anecdotal evidence to suggest that people with CCSVI do well with treatment. Again, as a vascular surgeon I do not treat MS; I treat CCSVI.
On June 1st, 2010. See this statement in context.